[Evaluation of efficacy and safety of intrabronchial specific immunotherapy with allergy medication against allergies to house mites among patients with bronchial asthma].
The purpose of this study was to evaluate efficacy and safety of local immunotherapy with inhaled allergens of house dust mites in asthmatic patients. An opened study was conducted in a group of 16 patients who have undergone 7 months course of immunotherapy. It has been shown statistically significant decrease in a score of clinical symptoms and in administered medications. On the other hand it has been demonstrated statistically significant increase of PEF in these patients. A decrease in specific and non-specific bronchial hyperreactivity has been revealed in bronchial provocation tests. Specific, local immunotherapy seems to be efficacious and well-tolerated way of hyposensitisation in house dust mite allergic patients.